Skin biopsies for early diagnosis and prognosis of graft-versus-host disease in recipients of allogeneic stem cells from blood or bone marrow

Bone Marrow Transplantation

Volumn 34, Issue 4, 2004, Pages 345-350

  Heldal, Dag ^a,b   Brinch, L ^a   Evensen, S A ^a   Tjonnfjord G E ^a   Aamodt, G ^a   Elgjo, K ^b   Sviland, L ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acute GVHD; Allogeneic stem cell transplantation; BM; BSC; Skin biopsies

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOTOXIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; STEROID;

ACUTE DISEASE; ADOLESCENT; ADULT; ALLOGRAFT; ALLOTRANSPLANTATION; ARTICLE; BONE MARROW; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFORMED CONSENT; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SKIN BIOPSY; STEM CELL; STEM CELL TRANSPLANTATION; SUPPRESSOR CELL;

ADOLESCENT; ADULT; ANTIGENS, CD; BIOPSY; BONE MARROW TRANSPLANTATION; FEMALE; GRAFT VS HOST DISEASE; HUMANS; INTESTINAL MUCOSA; LEUKEMIA; LIVER; MALE; MIDDLE AGED; SKIN; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 4444228640     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704568     Document Type: Article

References (28)

1. Ringdén O, Deeg HJ. Clinical spectrum of graft-versus-host disease. In: Ferrara JLM, Deeg HJ, Burakoff SJ (eds.). Graft-Versus-Host Disease. Marcel Dekker: New York, 1997; pp 525-559.
2. Weaver CH, Longin K, Buckner CD, Bensinger W. Lymphocyte content in peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Bone Marrow Transplant 1994; 13: 411-415.
3. dim) and lymphoid subsets, and possible predictors of engraftment and GVHD. Blood 1995; 86: 2842-2848.
4. Vigorito AC, Azevedo WM, Marques JF et al. A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies. Bone Marrow Transplant 1998; 22: 1145-1151.
5. Blaise D, Kuentz M, Fortanier C et al. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukaemia: a report from the Société Française de Greffe de Moelle. J Clin Oncol 2000; 18: 537-546.
6. Powles R, Mehta J, Kulkarni S et al. Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial. Lancet 2000; 355: 1231-1237.
7. Heldal D, Tjønnfjord G, Brinch L et al. A randomised study of allogeneic transplantation with stem cells from blood or bone marrow. Bone Marrow Transplant 2000; 25: 1129-1136.
8. Couban S, Simpson DR, Barnett MJ et al. A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. Blood 2002; 100: 1525-1531.
9. Bensinger WI, Martin PJ, Storer B et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001; 3: 175-181.
10. Schmitz N, Beksac M, Hasenclever D et al. Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukaemia. Blood 2002; 100: 761-767.
11. Mohty M, Kuentz M, Michallet M et al. Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study. Blood 2002; 100: 3128-3134.
12. Heldal D, Brinch L, Tjønnfjord G et al. Fewer relapses and increased chronic GVHD in patients transplanted with blood stem cells: a 5-year follow-up in a single centre study. Bone Marrow Transplant 2003; 32: 257-264.
13. Hepburn NC, McLaren KM, Turner ML, Beveridge GW. The role of skin biopsies in bone marrow recipients. Q J Med 1993; 86: 715-717.
14. Esteban JM, Somlo G. Skin biopsy in allogeneic and autologous bone marrow transplant patients: a histologic and immunohistochemical study and review of the literature. Mod Pathol 1995; 8: 59-64.
15. Diamond DJ, Chang KL, Jenkins KA, Forman SJ. Immunohistochemical analysis of T cell phenotypes in patients with graft-versus-host disease following allogeneic bone marrow transplantation. Transplantation 1995; 10: 1436-1444.
16. Kohler S, Hendrickson MR, Chao NJ, Smoller BR. Value of skin biopsies in assessing prognosis and progression of acute graft-versus-host disease. Am J Surg Pathol 1997; 21: 988-996.
17. Dickinson AM, Sviland L, Wang XN. Predicting graft-versus-host disease in HLA-identical bone marrow transplant: a comparison of T-cell frequency analysis and a human skin explant model. Transplantation 1998; 66: 857-863.
18. Dickinson A, Hromadnikova I, Sviland L. Use of a skin explant model for predicting GVHD in HLA-matched bone marrow transplants effect of GVHD prophylaxis. Bone Marrow Transplant 1999; 24: 857-863.
19. Sviland L, Dickinson AM. A human skin explant model for predicting graft-versus-host disease following bone marrow transplantation. J Clin Pathol 1999; 52: 910-913.
20. Sviland L. The pathology of bone marrow transplantation. Curr Diagn Pathol 2000; 6: 242-250.
21. Glucksberg H, Storb R, Fefer A et al. Clinical manifestation of graft-versus-host disease in human recipients of marrow from HLA matched sibling donors. Transplantation 1974; 18: 295-304.
22. Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-217.
23. Lerner KG, Kao GF, Storb CD. Histopathology of graft-versus-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc 1974; 6: 367-371.
24. Leskinen R, Taskinen E, Volin L et al. Immunohistology of skin and rectum biopsies in bone marrow transplant recipients. APMIS 1992; 100: 1115-1122.
25. Favre A, Cerri A, Bacigalupo A, Lanino E et al. Immunohistochemical study of skin lesions in acute and chronic graft versus host disease following bone marrow transplantation. Am J Surg Pathol 1997; 21: 23-34.
26. Yamada H, Chihara J, Hamada K et al. Immunohistology of skin and oral biopsies in graft-versus-host disease after bone marrow transplantation and cytokine therapy. J Allergy Clin Immunol 1997; 100: 73-76.
27. Sviland L, Pearson ADJ, Eastham EJ et al. Class II antigen expression by keratincytes - an early feature of graft-versus-host disease. Transplantation 1988; 46: 402-406.
28. Loughran TP, Sullivan K, Morton T et al. Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantation. Blood 1990; 76: 228-234.